BL
CLRB icon

Bleichroeder LP’s Cellectar Biosciences CLRB Stock Holding History

Bleichroeder LP’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$803K Buy
288,679
+188,679
+189% +$528K 0.14% 48
2026
Q1 		$254K Hold
100,000
– – 0.04% 56
2025
Q4 		$295K Hold
100,000
– – 0.05% 52
2025
Q3 		$560K Buy
+100,000
New +$495K 0.11% 45

Other funds holding CLRB

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $349M AUM 33.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bleichroeder LP's CLRB Position: Q2 2026 in Review

Bleichroeder LP increased its Cellectar Biosciences (CLRB) stake by 189% in Q2 2026, buying an estimated $528K and bringing the position to 288,679 shares worth $803K. The position accounts for 0.14% of the portfolio, ranked #48.

Bleichroeder LP first reported a position in CLRB in Q3 2025 and has held it in 4 quarters since. 18 funds tracked by Wall St. Rank hold CLRB as of Q2 2026.

  • Bleichroeder LP held 288,679 shares of Cellectar Biosciences worth $803K as of Q2 2026.
  • Bleichroeder LP bought 188,679 Cellectar Biosciences shares in Q2 2026, an estimated $528K.
  • Cellectar Biosciences made up 0.14% of Bleichroeder LP's portfolio in Q2 2026, its #48 holding.
  • Bleichroeder LP first reported a position in Cellectar Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 18 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q2 2026.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.